| 000 | 01748 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513220619.0 | ||
| 264 | 0 | _c20001010 | |
| 008 | 200010s 0 0 eng d | ||
| 022 | _a0021-9525 | ||
| 024 | 7 |
_a10.1083/jcb.150.5.1027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avon Ahsen, O | |
| 245 | 0 | 0 |
_aPreservation of mitochondrial structure and function after Bid- or Bax-mediated cytochrome c release. _h[electronic resource] |
| 260 |
_bThe Journal of cell biology _cSep 2000 |
||
| 300 |
_a1027-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBH3 Interacting Domain Death Agonist Protein |
| 650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 |
_aCytochrome c Group _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHL-60 Cells |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Membranes _xdrug effects |
| 650 | 0 | 4 |
_aMitochondria _xphysiology |
| 650 | 0 | 4 |
_aOocytes _xphysiology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-bcl-2 |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 |
_aStaurosporine _xpharmacology |
| 650 | 0 | 4 | _aUltraviolet Rays |
| 650 | 0 | 4 | _aXenopus laevis |
| 650 | 0 | 4 | _abcl-2-Associated X Protein |
| 700 | 1 | _aRenken, C | |
| 700 | 1 | _aPerkins, G | |
| 700 | 1 | _aKluck, R M | |
| 700 | 1 | _aBossy-Wetzel, E | |
| 700 | 1 | _aNewmeyer, D D | |
| 773 | 0 |
_tThe Journal of cell biology _gvol. 150 _gno. 5 _gp. 1027-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1083/jcb.150.5.1027 _zAvailable from publisher's website |
| 999 |
_c10921388 _d10921388 |
||